| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824576 | Clinical Therapeutics | 2016 | 9 Pages |
Abstract
Unselective use of ivabradine in patients with stable CAD is not supported by evidence and can be associated with new-onset atrial fibrillation, bradycardia, and drug-related nuisance adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Carolyn PharmD, RPh, Matthew PharmD, RPh, BCPS, Morgan PharmD, RPh, CDE, Jennifer L. PharmD, RPh, Michael J. PharmD,